Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease
from NDTV Profit - Latest https://ift.tt/2NBoYsp
from NDTV Profit - Latest https://ift.tt/2NBoYsp
Cadila Healthcare Gains Over 2% After Unit Buys Drug For Menkes Disease
![Cadila Healthcare Gains Over 2% After Unit Buys Drug For Menkes Disease]()
Reviewed by placements page
on
February 24, 2021
Rating:
No comments: